erythrosine has been researched along with cytarabine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khoobehi, B; Magin, RL; McTurnan, WG; Niesman, MR; Peyman, GA | 1 |
| Chi, JC; Holtzer, H; Rubinstein, NA | 1 |
| Erlichman, C; Hedley, DW; Jamieson, GP; Pressacco, J; Wiley, JS | 1 |
| Fridborg, H; Killander, A; Kristensen, J; Larsson, R; Liliemark, J; Nygren, P; Oberg, G; Simonsson, B | 1 |
| Brocklebank, AM; Buolamwini, JK; Jamieson, GP; Paterson, AR; Sawyer, WH; Snook, MB; Wiley, JS | 1 |
| Belch, AR; Gati, WP; Larratt, LM; Paterson, AR; Turner, AR | 1 |
| Belch, AR; Chlumecky, V; Gati, WP; Larratt, LM; Mant, MJ; Paterson, AR; Turner, AR | 1 |
| Bartkowiak, D; Baust, H; Högner, S; Nothdurft, W; Röttinger, EM | 1 |
| Campone, M; Le Cabellec, MT; Meflah, K; Oliver, L; Vallette, FM; Vavasseur, F | 1 |
| Albertioni, F; Eriksson, S; Löfgren, C; Månsson, E; Paul, A; Paul, C; Ullberg, K | 1 |
| Anagnostopoulos, N; Androutsos, G; Galanopoulos, A; Kalmantis, T; Meletis, J; Paterakis, G; Rombos, Y; Sagriotis, A; Symeonidis, A; Tiniakou, M; Tsimberidou, AM; Yataganas, X; Zoumbos, N | 1 |
| Asano, S; Chen, MH; Izawa, K; Kobayashi, S; Maruyama, K; Soda, Y; Tani, K; Tojo, A | 1 |
1 review(s) available for erythrosine and cytarabine
| Article | Year |
|---|---|
Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).
Topics: Acute Disease; Antimetabolites, Antineoplastic; Carrier Proteins; Cytarabine; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Gene Expression; Humans; Leukemia, Myeloid, Acute; Lymphocytes; Membrane Proteins; Microscopy, Confocal; Nucleoside Transport Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purine Nucleosides | 1998 |
11 other study(ies) available for erythrosine and cytarabine
| Article | Year |
|---|---|
Externally triggered release of dye and drugs from liposomes into the eye. An in vitro and in vivo study.
Topics: Animals; Anterior Chamber; Cytarabine; Eye; Fluoresceins; In Vitro Techniques; Liposomes; Rabbits | 1988 |
Actin and myosin in a variety of myogenic and non-myogenic cells.
Topics: Actins; Adenosine Triphosphatases; Animals; Bromodeoxyuridine; Calcium; Carbon Radioisotopes; Cells, Cultured; Chick Embryo; Cytarabine; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Fibroblasts; Fluoresceins; Leucine; Magnesium; Molecular Weight; Muscles; Myosins; Potassium; Time Factors; Tritium; Trypsin | 1974 |
Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis.
Topics: Antimetabolites; Carrier Proteins; Cytarabine; DNA; Fluoresceins; Fluorouracil; Humans; Membrane Proteins; Nucleoside Transport Proteins; Purine Nucleosides; Thymine Nucleotides; Tumor Cells, Cultured | 1995 |
Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Agents; Cladribine; Cytarabine; Daunorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Fluoresceins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Tumor Cells, Cultured | 1994 |
Flow cytometric quantitation of nucleoside transporter sites on human leukemic cells.
Topics: Adenosine; Binding Sites; Carrier Proteins; Cell Line; Cytarabine; Fluoresceins; Humans; Leukemia, Myeloid; Ligands; Membrane Proteins; Nucleoside Transport Proteins; Purine Nucleosides; Thioinosine; Thionucleosides | 1993 |
Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein.
Topics: Acute Disease; Adenosine; Affinity Labels; Antimetabolites, Antineoplastic; Carrier Proteins; Cell Death; Cytarabine; Flow Cytometry; Fluorescein; Fluoresceins; Humans; Leukemia; Nucleosides; Thionucleosides; Tumor Cells, Cultured | 1997 |
Comparative analysis of apoptosis in HL60 detected by annexin-V and fluorescein-diacetate.
Topics: Annexin A5; Apoptosis; Cell Separation; Cytarabine; Flow Cytometry; Fluoresceins; HL-60 Cells; Hot Temperature; Humans; Propidium; Scattering, Radiation; Topotecan | 1999 |
Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspases; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Enzyme Activation; Flow Cytometry; Fluoresceins; HL-60 Cells; Humans; Peptide Hydrolases; Phenotype; Probenecid; Protein Biosynthesis; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; X-Linked Inhibitor of Apoptosis Protein | 2001 |
Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cyclosporins; Cytarabine; Deoxycytidine Kinase; DNA Fragmentation; Doxorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluoresceins; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute | 2001 |
Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; Calcium Channel Blockers; Carbocyanines; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Fluoresceins; Fluorescent Dyes; Genistein; Humans; Idarubicin; Immunophenotyping; Leukemia, Myeloid; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Probenecid; Prognosis; Prospective Studies; Rhodamine 123; Survival Analysis; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles; Verapamil | 2002 |
A versatile drug delivery system using streptavidin-tagged pegylated liposomes and biotinylated biomaterials.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD7; Biological Transport; Biotinylation; Cell Survival; Chemistry, Pharmaceutical; Cytarabine; Dose-Response Relationship, Drug; Female; Fluoresceins; Fluorescent Dyes; Granulocyte Colony-Stimulating Factor; Humans; Inhibitory Concentration 50; Jurkat Cells; K562 Cells; Leukemia; Lipids; Liposomes; Mice; Mice, Inbred NOD; Mice, SCID; Polyethylene Glycols; Receptors, Granulocyte Colony-Stimulating Factor; Sialic Acid Binding Ig-like Lectin 3; Streptavidin; Technology, Pharmaceutical; Xenograft Model Antitumor Assays | 2013 |